Nasdaq-listed oncology firm launches regional HQ in Singapore
Guardant Health AMEA has distributorships in key markets including S-E Asia, HK, NZ and Israel
Claudia Chong
Singapore
NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.
Guardant Health helps medical professionals decide which therapy may be effective for advanced stage cancer patients with solid tumours. It does so through liquid biopsy tests for comprehensive genomic profiling and big data analytics. A liquid biopsy is a test done on a sample of blood to look for cancer cells.
TRENDING NOW
Why US$100 oil, 5% US yields affect Singdollar, ringgit differently vs other Asean currencies
Anthropic to open Singapore office in October, sees it as ‘standout market’ for Claude
Singapore’s covered bond boom is largely a DBS story
Malaysian developer Eco World tops bids for Sin Ming area housing plot with S$1,612 psf ppr offer
